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Abstract: A sustainable food supply is an ever-growing public and planetary health concern influenced
by food culture, food practices, and dietary patterns. Globally, the consumption of plant foods that
offer physiological and biochemical benefits is increasing. In recent years, products made from
yacon (Smallanthus sonchifolius) tubers and leaves, e.g., in the form of syrup, powder, and herbal tea,
have steadily emerged with scientific evidence to validate their possible health claims. Yacon was
introduced to New Zealand in 1966, and its products can now be produced on a commercial scale.
This paper reviews literature published mainly in the last 10 years concerning the health-related
properties of yacon as a wholesome foodstuff and its bioactive components, e.g., fructooligosaccharides.
Literature was sourced from Web of Science, PubMed, EBSCO Health, and Google Scholar up to
June 2019. The potential markets for yacon in the field of food technology and new dietotherapy
applications are discussed. Furthermore, the unique features of New Zealand-produced yacon syrup
are introduced as a case study. The paper explores the scientific foundation in response to the growing
public interest in why and how to use yacon.
Keywords: yacon; public health; chronic diseases; prebiotic; fructooligosaccharides; inulin;
phenolic compounds
1. Introduction
A sustainable food supply is an ever-growing public and planetary health concern influenced
by food culture, food practices, and dietary patterns. Globally, the consumption of plant foods that
offer physiological and biochemical benefits is increasing [1,2]. In recent years, products made from
yacon (Smallanthus sonchifolius) tubers and leaves, such as syrup, powder, and herbal tea, have steadily
emerged with scientific evidence to validate their applications. Yacon is perceived as a functional food
because it contains biologically active components that may provide physiological benefits beyond
basic nutritional functions to reduce the risk of chronic diseases [3,4]. Yacon, originally from South
America, is now consumed in some countries such as Japan, South Korea, and China, but it is relatively
new to the global market [5,6]. Its health-related properties are closely associated with its abundant
bioactive components [7,8].
In vivo studies in animal models have shown yacon’s biological effects on glycemic control, as well
as its reductions of plasma cholesterol and low density lipoprotein (LDL) [9–12]. Clinical evidence from
human studies is currently limited. Some studies have demonstrated that the consumption of yacon has
positive health effects including anti-cancer [13], anti-inflammatory and antioxidant activity related to
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its phenolic compounds [14], immunity improvement in preschool children [15], diabetes management
in the elderly [16,17], weight management, and obesity prevention in overweight adults [17–20],
all of which have been reported to be associated with the content of fructooligosaccharides (FOS) and
inulins. In addition, yacon has potential markets in the development of new food products and new
dietotherapy applications [4,5,21].
This paper reviews literature published mainly in the last 10 years that concerns the nutritional
and chemical composition of yacon, the health-related properties of yacon as a wholesome foodstuff,
and the bioactive components of yacon. Literature was sourced from Web of Science, PubMed,
EBSCO Health, and Google Scholar up to June 2019. The potential markets for yacon in the field of
food technology and new dietotherapy applications are discussed. Further, the unique features of
New Zealand-produced yacon syrup are introduced as a case study. The paper explores the scientific
foundation in response to the growing public interest in why and how to use yacon.
2. Yacon, and Nutritional and Chemical Composition
Yacon is a plant native to South America, where it is consumed as food and is used in folk medicine
for treating diabetes, constipation, and other diseases [7,22]. The plant grows well in warm, low frost
areas and, in most conditions, does not require pesticides for protection from fungi and insects.
Yacon is a perennial herbaceous plant that has sweet-tasting-tuberous roots (Figure 1). The roots
are often referred to as tubers, have a tan-colored thin skin, and have crisp flesh. The main substances
in fresh yacon roots are: water (>70%), carbohydrates (20%, of which 80% are FOS and inulin),
protein (2%), lipid (1%), and ash (2%) [7,8]. The content of carbohydrates in the dry matter of
yacon roots is approximately 94% [7]. Apart from free sugars, e.g., glucose, fructose, and sucrose,
yacon roots store carbohydrates in the form of fructans, unlike most plant roots in the human diet
that store carbohydrates in the form of starch [17,21,23]. A fructan is a polymer of fructose molecules.
Fructans with a short-chain are known as FOS (the degree of polymerization (DP) < 9), and long-chain
linear fructans are inulins (DP up to 60). Both FOS and inulin are β-D-fructafuranoses joined by a
β-(2,1) bond [24].Nutrients 2019, 11, x FOR PEER REVIEW 3 of 17 
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Both the leaves and tubers of yacon contain significant quantities of bioactive compounds.
The leaves of yacon contain protocatechuic, chlorogenic, caffeic, and ferulic acids (Figure 1), which give
antidiabetic and antioxidant properties to infusions (herbal teas) made from the leaves [25–27]. The roots
of yacon contain antioxidants, fructose, glucose, sucrose, and β-(2,1) fructooligosaccharides (inulin-type
oligofructans) [6–8]. Inulin-type oligofructans are fermented by beneficial species of gut bacteria and
may thus be prospective prebiotics [28]. In addition, phenolic acids occur in both the leaves and roots
of yacon. Some compounds have been identified as caffeic acid and its derivatives, chlorogenic acid
and L-tryptophan [29]. Moreover, yacon roots have a high amount of phenolic compounds (about
200 mg in 100 g of edible fresh matter) compared to other plant roots and tubers [21].
The chemical composition of yacon leaves and tubers may vary depending on factors including
planting location, growing season, and harvest time. The FOS content in New Zealand-grown yacon
tubers has been shown to vary from 58% to 78% of the total carbohydrates [30]. The ratio of FOS to
free sugars depends on the stage of development of the crop, as well as the time and temperature of
post-harvest storage.
3. Health Effects (Usually Benefits) of Yacon and Its Bioactive Components
Human studies on yacon are currently limited. Most of the in vivo studies have been conducted
in animal models. However, studies on individual components such as FOS, inulin, and phenolic
compounds could reflect the health effects or benefits of yacon to humans. The health effects of either
yacon as a whole or each functional component of yacon are now reviewed in detail.
3.1. Health Effects of Fructooligosaccharides (FOS)
Fructooligosaccharides are short-chain oligosaccharide fructans (DP < 9) that occur naturally in
the cell vacuoles of plant leaves, stems, and roots. FOS can be extracted from plants, fruits, vegetables,
and some grains and cereals such as wheat and barley. The content of FOS and inulin-type fructans is
up to 70% of the dry matter of yacon roots. The highest concentration of FOS of cultured plants has
been found in yacon [21,23,31] in the order of 16% fresh weight.
As soluble fibers, FOS are commonly used as a low-calorie alternative sweetener and is now
increasingly popular for its prebiotic effects [22,32]. This is because amylases cannot hydrolyze β-(2,1)
bonds, and FOS are resistant to enzymatic hydrolysis by salivary and intestinal digestive enzymes,
thus passing through the upper gastrointestinal tract without being metabolized before it is fermented
by anaerobic bacteria in the colon to terminal products—short chain fatty acids (SCFA) [33,34].
The human intestinal microflora are composed of more than 400 species, and the colon is the region
with the highest microbial population. FOS have an indirect influence on immunity through SCFA
production. Research in animal models has suggested that SCFA production by FOS fermentation in
the colon can increase local immune response, reduce colon pH, and, therefore, suppress inflammation
and in the longer term development of colorectal cancer [35,36].
At the genus level, both FOS and SCFA support the growth of beneficial bacteria such as
Bifidobacteria spp. and Lactobacillus spp. [7,37–39] (Figure 2). Bifidobacteria constitute 25%–30% of the total
population of the gut bacteria, while Lactobacillus constitute less than 1% of the gut bacterial population.
Probiotic strains of Lactobacilli and Bifidobacteria potentially alter gut microbiology. Their optimization
in the intestinal microflora can ease constipation, improve serum lipids in hyperlipidemia, and suppress
the production of intestinal putrefactive substances in the digestive tract.
In a detailed mouse model, Delgado et al. [40,41] reported that the consumption of fructans
increased immune system efficiency. The daily intake of FOS for 30 days has been shown to lead to an
improvement in anti-inflammatory state in phagocytic cells and mucosal immunity associated with
reduced risks for autoimmune and metabolic diseases. Velez et el. [42] found that the oral administration
of yacon root flour in mice regulated intestinal microbiota balance and had immunomodulatory effects
without inflammatory responses. Moreover, they demonstrated that yacon flour could be useful
in preventing infection caused by Salmonella typhimurium. A human study in preschool children
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(n = 59, age of 2–5 years) demonstrated improved intestinal immune responses shown by secretory
immunoglobulin A (IgA) concentrations after the daily consumption of 0.14 g of FOS per kilogram of
body weight for 18 weeks [15]; there was no effect on the nutritional status of iron and zinc.
In other studies, FOS supplementation has been shown to improve growth performance [43],
mineral absorption [44], and bowel function [45].
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Due to its non-digestible pr perty, FOS have a low glycemic impact. A randomized, d uble-blind
trial in obese adults (body ass index (BMI) 25–30 kg m-2) reported that the daily i take of 20 g of
FOS (n = 40) for three months resulted in a significant reduction of atherogenesis and bod weight,
compared with placebo control (n = 32) [18].
FOS are rec gnized as generally safe by the Food and Drug Admi istration (FDA) and verified by
clinical studies [46,47]. However, the side effects of FOS consumption including digestive upset and
abdominal stress should be take into account when used as dietary supplements or food ingredients,
in particular in baby formula [48].
3.2. Health Effects of Inulin
Inulins are fructan-type polysaccharides (DP up to 60) that occur in many plant roots, fruits,
vegetables, and some grains and cereals. Inulin and FOS, both fructans, are the main constituents in
the dry matter of yacon roots [4,8]. The favorable characteristics that apply to FOS are very likely to
apply to inulins.
Inulin is soluble in water and therefore classed as soluble fiber [49]. Because of the β-(2, 1) linkages,
inulin is not digested by enzymes in the upper gastrointestinal tract but is fermented in the colon,
contributing to its reduced calorie value and prebiotic properties. Inulin is commonly used in the
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food industry as a low-calorie sweetener; a texture modifier in dairy products such as yogurt, cheese,
milk drinks [49,50]; and as dietary fiber and prebiotics used in functional foods [51,52].
Similar to FOS, the functional effects of inulins include promoting digestive health as prebiotics
and contributing to the production of colon butyrate, which is associated with a reduced risk of colon
cancer and breast cancer [21,53]. Moreover, due to its non-digestible feature, inulin has a favorable
impact on blood glucose concentration when consumed with other foods. Inulin supplementation has
been positively associated with a reduced fasting glucose and fasting insulin concentration in type
2 diabetes patients [54].
Inulins are generally recognized as safe [46,47]. Their side effects may include intestinal discomfort
and allergic reactions [55].
3.3. Health Effects of Phenolic Compounds
Phenolic compounds are a dominant class of secondary metabolites in plants which comprise
hydroxy groups bonded to an aromatic hydrocarbon groups (benzene rings) and range from simple to
high polymeric compounds [56,57]. Compared to other plant roots and tubers, yacon roots have a high
concentration of phenolic compounds, about 200 mg in 100 g of edible fresh matter [21].
Recently, phenolic compounds have been of growing interest to health professionals and the food
industry for their potential health benefits—antioxidant properties, in particular. Phenolic compounds
have antioxidant capacities that are related to the hydroxyl groups and the conjugated double
bonds of the benzene ring [58], which together act as quenching agents of deleterious free radicals.
Epidemiological studies have suggested the potential health effects of phenolic compounds in the
prevention of many chronic diseases such as diabetes, cancers, and cardiovascular diseases [59,60],
all potentially arising from their antioxidants, anti-inflammatory [61,62], and anti-carcinogenic
functional properties [63,64].
Because of the anti-inflammatory effect associated with antioxidant activity, polyphenols have been
proposed to be useful for the development of future antioxidant therapeutics and anti-inflammatory
drugs [62].
3.4. Health Effects of Yacon Leaf and Tuber
Though it is relatively new to the global market due to its lack of availability and low popularity,
yacon has been considered as a functional food with multiple physiological properties related to its
bioactive compounds [4,5] in both its leaves and tubers; these properties include those of anti-cancer,
antioxidative, antimicrobial, antidiabetic, anti-obesity and weight management. These properties
can almost certainly be ascribed to FOS, inulin and phenolics, and this is the theme of the studies
described now.
Yacon leaves have been traditionally used in the Andes to treat people suffering from diabetes
and digestive diseases. In experimental trials, dos Santos et al. [12,65] reported a significant reduction
of glycemia, an increase in insulin concentration, and a decrease in serum triacylglycerol concentration
in streptozotocin-induced diabetic rats after the oral administration of yacon leaf extract for 30 days.
Valentova et al. [66] and other studies [67–70] reported the anti-hyperglycemic effects of yacon leaf
extract in animal models.
Yacon leaves are pest-resistant and antimicrobial, and these properties are associated with the
content of monoterpenes, sesquiterpenes, and diterpenes [25,71]. In in vitro studies, sesquiterpene
lactones from yacon leaves have been shown to strongly inhibit cancer cell deformation and
proliferation [13,72–74]. The extracts of dried leaves have shown antioxidant function related to their
phenolic content. Valentova et al. [26] proposed that yacon leaves can be used as a potential remedy in the
prevention of chronic diseases caused by free radicals, e.g., arteriosclerosis. Moreover, Oliveira et al. [75]
reported the topical anti-inflammatory activity of yacon leaf extracts. The extracts were proven to have
in vivo anti-edematogenic activity and could be potential anti-inflammatory agents.
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Yacon roots are rich in phenolic compounds and are therefore a potential novel source of
antioxidants [14,39,76]. Moreover, because of its high content of inulin and FOS (up to 70% of the dry
matter of the yacon root), yacon has shown important prebiotic characteristics.
Yacon roots possess anti-cancer, antioxidative, and antimicrobial properties [7,77–82]. An ethanol
extract of yacon, which is rich in phenolics, inhibited the cell proliferation and migration of C6 glioma
cells stimulated with fetal bovine serum [81]. The oral administration of the aqueous extract of yacon
roots and Lactobacillus acidophilus had protective effects against colon carcinogenesis on the early phases
of tumor development in rats [77,83].
Studies in preschool children (n = 59, age of 2–5 years) have demonstrated improved intestinal
immune responses shown by secretory IgA concentrations after the daily consumption of yacon root
flour (0.14 g of FOS per kilogram of body weight) for 18 weeks [15], but no effect on the nutritional
status of iron and zinc was demonstrated. Some studies have reported improved mineral absorption
in animal models after the consumption of yacon flour containing fructan [10,84,85].
The antidiabetic effects of yacon roots have been proven in animal models and human studies.
An improvement of biochemical parameters in type 1 diabetic rats was observed after oral treatment
by the aqueous extract of yacon roots [80]. The hypoglycemic effects of yacon tuber extracts and their
phenolic constituent, chlorogenic acid, have been demonstrated in diabetic rats [11]. Habib et al. [78,79]
reported that the administration of FOS-rich yacon flour to diabetic rats for 90 days led to a significant
decrease in fasting plasma triacylglycerol and very low density lipoprotein concentrations but a
slight increase in fasting plasma insulin concentrations [78], as well as a significant decrease in
malondialdehyde levels in both liver and kidney [79]. Malondialdehyde is a marker of deleterious fat
oxidation. Furthermore, a yacon-enriched diet has been shown to improve insulin resistance in insulin
resistant rats that could favor blood glucose control [41]. In a controlled trial with elderly subjects
(aged over 60 years), the daily consumption of 18 g of freeze-dried yacon powder containing 7.4 g of
FOS for nine weeks resulted in a decrease in serum glucose, but no reduction was observed in serum
lipids [16].
The effects of yacon on weight management and obesity prevention are mainly related to the
high content of the non-digestible FOS and phenolic compounds. Feeding rats with yacon flour for
12 weeks has demonstrated an improvement of visceral adiposity and metabolic parameters [86].
The administration of an aqueous extract of yacon root containing 4.3% of fructans (1 mL of the extract
per kilogram of body weight) for seven weeks has been shown to improve lipid profiles by a reduced
triacylglycerol concentration and an increased high-density lipoprotein cholesterol concentration in
diabetic rats [87]. In human studies, the daily consumption of a breakfast drink containing 25 g of
yacon flour for six weeks by overweight adults (BMI 30 ± 2.4 kg m−2, body fat 40 ± 6.7%) resulted in
reduction in body weight, body fat, waist circumference, and sagittal abdominal diameter [19].
In terms of promoting gastrointestinal health, Utami et al. [88] demonstrated that compared
with commercial FOS, yacon tuber (containing same amount of FOS) consumption promoted the
growth of Bifidobacteria and Lactobacillus in the rat cecum, resulting in a greater concentration of SCFAs.
They concluded that the yacon tuber has more favorable effects in colonic health maintenance than
that of other FOS sources. It has been proposed that the yacon tuber also contains resistant starch and
polyphenols, both of which contribute to the difference in gut environment.
In behavioral despair animal models (mice), antidepressant-like effects have been observed after
inulin-type oligosaccharides extracted from yacon roots were administered; the results suggested that
yacon consumption has the potential to treat patients with depression [89].
The possible adverse effects of yacon have been investigated in animal models and human studies.
Genta et al. [90] reported that no toxicity and adverse side effects were observed in rats after four
months of the regular consumption of yacon root flour that provided 340 mg of FOS per kilogram of
body weight (this dose is likely the upper limit of human tolerance in long-term trials); in a human
study, there were no ill effects after 120 days of the supplementation of yacon syrup that provided 0.14 g
of FOS per kilogram of body weight [17]. However, there were side effects reported in two studies.
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One study reported the development of renal lesions in rats after 30 days of oral treatment with the
aqueous yacon leaf extract, where terpenoids were proposed to be the main toxic compounds in yacon
leaves [91]. Another study reported the development of anaphylactic reactions in a 55-year-old woman
after the ingestion of yacon root [92]. This appears to be an isolated response, but further studies are
needed to investigate the safety of yacon used as dietary supplements.
3.5. Others
Human and animal studies have demonstrated the health benefits of the consumption of yacon
in relation to health promotion and chronic diseases prevention. The in vitro and in vivo studies on
yacon in human or animal models are summarized in Table 1.
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Table 1. Summary of studies on yacon (Smallanthus sonchifolius) in vitro and in vivo in human or animal models.
Author(s) Year Stated Yacon Source Component(s) Under Study
Study Design
Physiological Effect(s)
Method In Vivo(Human Study or Animal Model)
Cocato et al. [10] 2019 Yacon root flour FOS* Rats (Wistar) Improved mineral absorption
Machado et al. [19] 2019 Yacon root flour FOS Human (BMI 30 ± 2.4 kg m-2) Improved body composition
dos Santos et al. [65] 2018 Yacon leaf extract Rats (Wistar) Significant reduction in glycemia
Gomes da Silva et al. [20] 2017 Yacon syrup Human Improved satiety effects
dos Santos et al. [12] 2017 Yacon leaf extract Rats (Wistar, diabetic) Improved glycemic control
An et al. [89] 2016 Yacon root extract Inulin Mice (Kuming);Rats (Sprague Dawley) Antidepressant-like effects
Baroni et al. [70] 2016 Yacon leaf extract Phenolics Rats (Wistar, diabetic) Improved insulin sensitivity
da Silva et al. [77] 2015 Yacon root extract FOS Rats (Wistar) Anti-cancer (against colon carcinogenesis on the early phases)
de Ford et al. [13] 2015 Yacon leaf extract In vitro Anti-cancer
Habib et al. [79] 2015 Yacon root flour Rats (Wistar, diabetic) Antidiabetic effects
Jimenez et al. [93] 2015 Yacon root FOS Rats (Wistar) Improved intestinal microflora
Lee et al. [81] 2015 Yacon extract In vitro Anti-cancer (inhibited cell proliferation)
Russo et al. [27] 2015 Yacon leaf extract Phenolics In vitro Antioxidant effects
Sousa et al. [82] 2015 Yacon tuber flour Phenolics In vitro Antioxidant effects
Sugahara et al. [94] 2015 Yacon leaf extract Phenolics In vitro Antioxidant effects
Scheid et al. [16] 2014 Yacon root powder FOS Human (>60 years old) Diabetes management, no side effects observed
Vaz-Tostes et al. [15] 2014 Yacon root flour FOS Human (ages 2–5 years old) Improved systemic immunity
Oliverra et al. [75] 2013 Yacon leaf extract In vitro Anti-inflammatory
Oliverra et al. [80] 2013 Yacon root extract Fructan Rats (induced type 1 diabetic) Antidiabetic effects
Satoh et al. [95] 2013 Yacon tuber extract Rats (Zucker fa/fa) Improved insulin sensitivity
Utami et al. [88] 2013 Yacon tuber powder FOS Rats (Sprague Dawley) Improved intestinal microflora
Velez et al. [42] 2013 Yacon root flour FOS Mice (BALB/c) Regulated intestinal microflora
Campos et al. [39] 2012 Yacon root flour FOS Guinea pig Improved intestinal microflora
Delgado et al. [41] 2012 Yacon root flour FOS Mice (BALB/c) Improved immunity efficiency
de Moura et al. [83] 2012 Yacon root extract FOS Rats (Wistar) Anti-cancer (against colon carcinogenesis on the early phases)
Roselino et al. [87] 2012 Yacon root extract Fructan Rats (Wistar) Improved lipid profiles
Habib et al. [78] 2011 Yacon root flour FOS Rats (Wistar) Antidiabetic and hypolipidemic effects
Lobo et al. [84] 2011 Yacon root flour Inulin Rats (Wistar) Improved mineral absorption
Siriwan et al. [72] 2011 Yacon leaf extract In vitro Anti-cancer (inhibited cancer cell proliferation)
Siriwan et al. [73] 2011 Yacon leaf extract In vitro Anti-cancer (inhibited cancer cell proliferation)
Bonet et al. [96] 2010 Yacon root flour Mice (BALB/c) Improved intestinal microflora (growth of Bifidobacteria and Lactobacilli)
Genta et al. [68] 2010 Yacon leaf extract Phenolics Rats (Wistar) Hypoglycemic effects
Joung et al. [71] 2010 Yacon leaf extract In vitro Antimicrobial effects
Raga et al. [69] 2010 Yacon leaf extract Phenolics Mice (albino) Hypoglycemic effects
Yun et al. [92] 2010 Yacon root ingestion Human (a 55-years-old woman) Anaphylaxis1
Genta et al. [17] 2009 Yacon syrup Human (obese with mild dyslipidemia) Improve insulin-resistance, and satiety effects
Park et al. [11] 2009 Yacon tuber extract Rats (Sprague Dawley, diabetic) Improved glycemic control
Baroni et al. [67] 2008 Yacon leaf extract Phenolics Rats (Wistar) Hypoglycemic effects
Geyer et al. [97] 2008 Yacon syrup FOS Human Improved the colonic transit
Lobo et al. [85] 2007 Yacon root flour Rats (Wistar) Improved mineral absorption
Genta et al. [90] 2005 Yacon root flour FOS Rats (Wistar) No adverse side effects observed2
Valentova et al. [66] 2004 Yacon leaf extract Rats (diabetic) Anti-hyperglycemic effects
* FOS: fructooligosaccharides. 1 A reported case of adverse side effects. 2 Toxicity study.
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4. Potential Dietotherapy Applications: How to Use Yacon
The global market value for prebiotics is currently worth more than US$ 3 billion. The concept
is well-known in Japan, Taiwan and South Korea, and it is becoming known in North America and
Western Europe. Yacon has a large potential in the application of food technology and in the prevention
of chronic diseases where, for instance, it is a potential novel source of prebiotics. Yacon tubers can
be consumed raw, cooked, or in the form of jam, syrup, vinegar, flour, chips (dried slices), and juice
as a novel food. The flesh is crisp like a nashi pear or water chestnut if consumed raw. In Japan,
yacon roots are processed into bakery products, fermented beverages, freeze-dried powder, and other
products [4,5,23]. The market position of FOS from yacon is natural and unprocessed. As a food
with multiple functions, yacon has potential dietotherapy applications that are associated with its
physiological and biochemical properties.
4.1. Yacon Tea
Yacon leaves are often used for herbal tea. Medicinal teas made from yacon leaves have been
shown to present hypoglycemic and hypocholesterolemic activities [26,66].
In Japan, the leaves of yacon are processed and marketed as an herbal tea in local markets.
Sugahara et al. [94] examined the effective antioxidative effects and suggested that yacon herbal tea
was a good natural source of antioxidants against free radicals.
4.2. Yacon Syrup
Yacon syrup is a novel product obtained from concentrating the juice of yacon tubers. Yacon syrup
is comprised of FOS, inulin, and a small amount of free sugars. It is used as a popular sugar substitute
due to its sweet flavor and low calorific impact [98].
To date, human trials have been very limited. There have been two studies reporting the
satiety-enhancing and anti-obesity effects in humans. The daily consumption of yacon syrup has been
shown to increase satiety sensation [17,20] and to result in a significant decrease in body weight over a
120-day period [17]. Yacon syrup could be well-positioned as a nutraceutical product because of its
naturally high FOS content [17]. A daily intake of 20 g of FOS or less in humans is generally considered
safe [90].
4.3. Yacon Powder
The commercial yacon powder products are available in health food and organic stores in producer
countries and Europe. The suggested use of yacon powder is as a dietary supplement.
4.4. Yacon Capsules
Yacon root extract is packed in the form of quick-release gelatine capsules for convenience.
Human studies on yacon capsules could not be found.
4.5. Yacon Used in Infant Formula
Yacon has a potential application in infant formulas due to its high content of non-digestible
carbohydrates [99,100], while considering that FOS are often included in formula.
4.6. Other Uses of Yacon
Other applications of yacon include its use as a natural source to treat depression [89], its use in
low-calorie bakery products (e.g., cake) as a partial substitute for flour related to its content of FOS and
inulin [101], and its use in beverages [102], in yoghurt [20] or in juice mixtures in Korea.
Yacon has a history of safe use as foodstuff and a source of prebiotics [23]. FOS (the major bioactive
component of yacon) have GRAS (generally regards as safe) status recognized by the FDA and its
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Japanese equivalent. Though the legal status of using yacon leaves as herbal tea could not be sourced,
the safe use of yacon leaves for their hypoglycemic effect was demonstrated by Barcellona et al. [103].
There are no known regulatory issues in South Korea and Taiwan. The Food Safety Authorities of
Australia, New Zealand, and European have approved the sale of yacon products in their markets.
5. Yacon New Zealand: A Case Study
The yacon plant was brought to New Zealand in 1966. It was introduced to Japan in 1985, and from
there, it was introduced to Korea, China, Indonesia, the Philippines and Brazil. Since 1995, the Crop
and Food Crown Research Institute has investigated the basic agronomy of yacon, and trials were
carried out in small plots in eight regions to optimize growing and harvesting conditions (Figure 3).
With its great volcanic soil, free draining, strong ultraviolet radiation, and mild climate, New Zealand
has the optimized conditions for growing high-FOS producing yacon. Yacon production is benefiting
from a tradition of high quality crop and horticulture production in New Zealand. In 2000, Yacon New
Zealand Ltd. purchased propagative material and the right to exclusive development. The crop is
currently grown and its products can be produced on a commercial scale. The composition of the
tubers is monitored during development, and they are harvested at the time of peak FOS content.
Nutrients 2019, 11, x FOR PEER REVIEW 11 of 17 
 
and its Japanese equivalent. Though the legal status of using yacon leaves as herbal tea could not be 
sourced, the safe use of yacon leaves for their hypoglycemic effect was demonstrated by Barcellona 
et al. [103]. There are no known regulatory issues in South Korea and Taiwan. The Food Safety 
Authorities of Australia, New Zealand, and European have approved the sale of yacon products in 
their markets. 
5. Yacon New Zealand: A Case Study 
The yacon plant was brought to New Zealand in 1966. It was introduced to Japan in 1985, and 
from there, it was introduced to Korea, China, Indonesia, the Philippines and Brazil. Since 1995, the 
Crop and Food Crown Research Institute has investigated the basic agronomy of yacon, and trials 
were carried out in small plots in eight regions to optimize growing and harvesting conditions (Figure 
3). With its great volcanic soil, free draining, strong ultraviolet radiation, and mild climate, New 
Zealand has the optimized conditions for growing high-FOS producing yacon. Yacon production is 
benefiting from a tradition of high quality crop and horticulture production in New Zealand. In 2000, 
Yacon New Zealand Ltd. purchased propagative material and the right to exclusive development. 
The crop is currently grown and its products can be produced on a commercial scale. The composition 
of the tubers is monitored during development, and they are harvested at the time of peak FOS 
content. 
 
Figure 3. Yacon plants were brought to New Zealand by Crop and Food Crown Research, and trials 
were carried out in small plots in different regions on the basic agronomy of the crop to optimize 
growing and harvesting conditions. 
Khajehei et al. [14] reported that New Zealand yacon has the lowest sugar content of all yacon 
varieties. Yacon New Zealand Ltd. produces yacon juice and further concentrated yacon syrup. 
Yacon juice has been sold to Korea and used as an ingredient in yoghurts or juice mixtures. The 
commercial product yacon syrup (NZFOS+) contains the purest natural prebiotic FOS from New 
Zealand-grown yacon. The product was tested for its glycemic index (GI) using the international 
standard methods ISO 26642:2010(E) [104] at the University of Sydney. Ten healthy subjects were 
recruited for the test. A standard 25 g glucose drink was used as a reference food. The results revealed 
that New Zealand-produced yacon syrup was low in its GI (GI = 40 ± 4). Ethical approval was 
obtained from the Human Research Ethics Committee of the University of Sydney. 
Mana Kai Rangahau
Yacon trial sites
Figure 3. Yacon plants were brought to New Zealand by Crop and Food Crown Research, and trials
were carried out in small plots in different regions on the basic agronomy of the crop to optimize
growing and harvesting conditions.
Khajehei et al. [14] reported that New Zealand yacon has the lowest sugar content of all
yacon varieties. Yacon New Zealand Ltd. produces yacon juice and further concentrated yacon
syrup. Yacon juice has been sold to Korea and used as an ingredient in yoghurts or juice mixtures.
The commercial product yacon syrup (NZFOS+) contains the purest natural prebiotic FOS from New
Zealand-grown yacon. The product was tested for its glycemic index (GI) using the international
standard methods ISO 26642:2010(E) [104] at the University of Sydney. Ten healthy subjects were
recruited for the test. A standard 25 g glucose drink was used as a reference food. The results revealed
that New Zealand-produced yacon syrup was low in its GI (GI = 40 ± 4). Ethical approval was obtained
from the Human Research Ethics Committee of the University of Sydney.
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Further work including in vitro fermentation investigation and clinical trials on yacon syrup
(NZFOS+) will be conducted at Plant Protection and Microbiology, Zhejiang Academy of Agricultural
Sciences in China.
6. Conclusions
In vitro and in vivo studies on yacon have shown the potential health benefits and dietotherapy
applications of yacon associated with the maintenance of health and wellbeing, as well as the prevention
of chronic diseases. Studies have also demonstrated that yacon is a safe food supplement without
significant adverse side effects. Further investigations are needed for human studies and new
applications and uses of yacon. In terms of yacon products such as yacon syrup and tea, these options
require labelling, branding, marketing and distributing to appropriate markets such as Japan, Taiwan,
South Korea, North America, and Europe where these concepts are accepted and the sale of yacon
products has been approved.
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